Article Details

Gossamer Bio nets $230M in series B to advance portfolio against undisclosed targets

Retrieved on: 2018-07-23 02:56:15

Tags for this article:

Click the tags to see associated articles and topics

Gossamer Bio nets $230M in series B to advance portfolio against undisclosed targets. View article details on hiswai:

Excerpt

<div>Gossamer's preferred stock funding round was led by Hillhouse Capital and included new investments from Invus, The <b>Baupost Group</b>, Polaris ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up